Term ends Oct 25, 2033 · Low confidence
20-year base term ends Oct 25, 2033
Oct 25, 2013
Oct 25, 2033
Feb 7, 2017
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: Low. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 25, 2013, when application PCT/US2013/066783, the earliest non-provisional in its chain, was filed (this one was filed Apr 21, 2015); a parent in its chain could not be resolved (the next row) | Oct 25, 2033 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,877,197, US 8,945,562, US 9,074,003, US 9,074,004, US 9,206,259, US 9,512,233, US 9,562,092) | resolves to Oct 25, 2033, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Oct 25, 2033 | Low confidence |
Partial family
| Application PCT/US2013/066783 | PCT application no patent term | no patent term |
| US 9,562,106 | this patent Oct 2033 | Oct 2033 |
| US 9,512,233 | In force Oct 2033 | Oct 2033 |
| US 10,457,745 | In force Oct 2033 | Oct 2033 |
| Application 16/575,265 | Abandoned not computed | not computed |
| US 12,215,169 | In force Oct 2033 | Oct 2033 |
| Application 18/989,593 | Pending not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 27, 2015 Reel 36186, frame 535 | Van Vlasselaer, Peter; Parry, Graham; Stagliano, Nancy E.; Panicker, Sandip | True North Therapeutics, Inc. | Assignment of Assignor's Interest |
| Oct 4, 2017 Reel 44126, frame 710 | True North Therapeutics, Inc. | Bioverativ USA Inc. | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 8,877,197, US 8,945,562, US 9,074,003, US 9,074,004, US 9,206,259, US 9,512,233, US 9,562,092, ends no earlier than this term, so it caps nothing.